Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
Deal Bird & Bird advises Brose Sitech on the acquisition of Proseat including its subsidiaries from Sekisui Kasei

Jul 07 2025

Read More
News Bird & Bird strengthens market-leading patent practice with Anna Wolters-Höhne in Hamburg

Jul 07 2025

Read More
News Bird & Bird acts for Willis Mitsui & Co Engine Support Limited in Acquisition of Bridgend Asset Management Limited

Jul 04 2025

Read More
News Bird & Bird partner Bill Smith relocates to the Middle East to head the Dispute Resolution practice

Jul 02 2025

Read More
News Bird & Bird boosts Commercial team in Sweden with new partner Mårten Lindberg

Jul 01 2025

Read More
News Bird & Bird advises Gprnt on seed funding round

Jun 27 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare